Abstract
Red blood cell (RBC) transfusions are a critical component of managing anemia in patients with acute leukemia and other hematological diseases. However, concerns regarding transfusion-related complications, resource utilization, and blood shortages have led to increased interest in restrictive transfusion strategies. This study evaluates the safety and efficacy of a single-unit RBC transfusion strategy compared to the conventional double-unit approach in hematological patients.This study including 200 patients undergoing treatment for acute leukemia or other hematological disorders. Patients were randomly assigned in a 1:1 ratio to receive either single-unit RBC transfusion (n = 100) or double-unit RBC transfusion (n = 100). The primary outcome was the composite incidence of severe complications, including ICU admission and 30-day mortality. Secondary outcomes included post-transfusion hemoglobin levels, transfusion-related adverse events, total RBC usage, hospital stay duration, and quality of life improvements. There were no significant differences between the single-unit and double-unit groups in ICU admission rates (12.3% vs. 11.8%, p = 0.72) or 30-day mortality (7.9% vs. 8.5%, p = 0.64). However, the single-unit group required significantly fewer transfusions (mean: 3.2 vs. 5.6 RBC units per patient, p < 0.001) and had longer transfusion intervals (10.3 vs. 8.1 days, p < 0.001). The hospital stay was shorter in the single-unit group (12.5 vs. 14.0 days, p = 0.03). While post-transfusion hemoglobin levels were higher in the double-unit group (9.3 vs. 8.5 g/dL, p < 0.001), this did not translate into improved clinical outcomes. Transfusion-related complications, particularly TACO, were more frequent in the double-unit group (4.0% vs. 1.7%, p = 0.05). The results demonstrate that a single-unit RBC transfusion strategy is non-inferior to the standard double-unit approach in terms of severe complications. Additionally, single-unit transfusion reduced overall RBC utilization, decreased transfusion-related complications, and shortened hospital stays. These findings support the adoption of restrictive transfusion protocols in hematological patients, especially in the context of blood shortages and resource optimization.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.